MANNKIND CORP·4

Feb 13, 9:30 PM ET

Marasco Dominic 4

4 · MANNKIND CORP · Filed Feb 13, 2025

Insider Transaction Report

Form 4
Period: 2025-02-12
Marasco Dominic
Pres, Endocrine Business Unit
Transactions
  • Award

    Common Stock, $0.01 Par Value

    2025-02-12+252,000252,000 total
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • [F2]Four-year vesting schedule with no shares vesting on the first anniversary of the vesting determination date of January 6, 2025 and one-third on each anniversary thereafter until fully vested on the fourth anniversary of the vesting determination date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4